抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Canertinib dihydrochloride，98% | C24H27Cl3FN5O3 | |||
|
|
|||||
|
TCS 359，99% | C18H20N2O4S | |||
|
|
|||||
|
SB431542，98% | C22H16N4O3 | |||
|
|
|||||
|
ZM 447439，98% | C29H31N5O4 | |||
|
|
|||||
|
Telatinib，98% | C20H16ClN5O3 | |||
|
|
|||||
|
CP-673451，≥98% | C24H27N5O2 | |||
|
|
|||||
|
N-Desethyl Sunitinib，95% | C20H23FN4O2 | |||
|
|
|||||
|
SB525334，99% | C21H21N5 | |||
|
|
|||||
|
Tandutinib (MLN518)，99% | C31H42N6O4 | |||
|
|
|||||
|
PHA-680632，98% | C28H35N7O2 | |||
|
|
|||||
|
CHIR-124，98% | C23H22ClN5O | |||
|
|
|||||
|
Dovitinib (TKI-258, CHIR-258)，99% | C21H21FN6O | |||
|
|
|||||
|
RepSox，99% | C17H13N5 | |||
|
|
|||||
|
BMS-536924，98% | C25H26ClN5O3 | |||
|
|
|||||
|
NVP-AEW541，≥98% | C27H29N5O | |||
|
|
|||||
|
PHA-665752，96% | C32H34Cl2N4O4S | |||
|
|
|||||
|
AEE788 (NVP-AEE788)，98% | C27H32N6 | |||
|
|
|||||
|
Terfenadine，98% | C32H41NO2 | |||
|
|
|||||
|
Icotinib，98% | ? C22H21N3O4 | |||
|
|
|||||
|
Oltipraz，99% | C8H6N2S3 | |||
|
|
|||||
|
BAY 61-3606 (dihydrochloride)，98% | C20H20Cl2N6O3 | |||
|
|
|||||
|
SU11274，98% | C28H30CIN5O4S | |||
|
|
|||||
